Degex Liquescence

Thuja Occidentalis, Ubidecarenonum, Conium Maculatum, Asterias Rubens, Germanium Metallicum, Lachesis Mutus, Bufo Rana, Carcinosin, Phosphorus · THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/mL; UBIDECARENONE 8 [hp_X]/mL; CONIUM MACULATUM FLOWERING TOP 9 [hp_X]/mL; ASTERIAS RUBENS 12 [hp_X]/mL; GERMANIUM 15 [hp_X]/mL; LACHESIS MUTA VENOM 12 [hp_X]/mL; BUFO BUFO CUTANEOUS GLAND 15 [hp_X]/mL; HUMAN BREAST TUMOR CELL 16 [hp_X]/mL; PHOSPHORUS 30 [hp_X]/mL · Liquid · Oral · Nutritional Specialties, Inc.

NDC 83027-0154-01 · 120 mL in 1 BOTTLE, GLASS · UNAPPROVED HOMEOPATHIC · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application: —
TE code: —
Approval date: —
Patents / exclusivity: —

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Thuja Occidentalis, Ubidecarenonum, Conium Maculatum, Asterias Rubens, Germanium Metallicum, Lachesis Mutus, Bufo Rana, Carcinosin, Phosphorus (Liquid)

Labeler	Strength	First seen	Last seen
Nutritional Specialties, Inc.	THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/mL; UBIDECARENONE 8 [hp_X]/mL; CONIUM MACULATUM FLOWERING TOP 9 [hp_X]/mL; ASTERIAS RUBENS 12 [hp_X]/mL; GERMANIUM 12 [hp_X]/mL; LACHESIS MUTA VENOM 12 [hp_X]/mL; BUFO BUFO CUTANEOUS GLAND 12 [hp_X]/mL; HUMAN BREAST TUMOR CELL 16 [hp_X]/mL; PHOSPHORUS 30 [hp_X]/mL	Aug 26, 2026	Sep 2, 2026
Nutritional Specialties, Inc.	THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/mL; UBIDECARENONE 8 [hp_X]/mL; CONIUM MACULATUM FLOWERING TOP 9 [hp_X]/mL; ASTERIAS RUBENS 12 [hp_X]/mL; GERMANIUM 15 [hp_X]/mL; LACHESIS MUTA VENOM 12 [hp_X]/mL; BUFO BUFO CUTANEOUS GLAND 15 [hp_X]/mL; HUMAN BREAST TUMOR CELL 16 [hp_X]/mL; PHOSPHORUS 30 [hp_X]/mL	Aug 26, 2026	Sep 2, 2026
Nutritional Specialties, Inc.	THUJA OCCIDENTALIS LEAFY TWIG 12 [hp_X]/mL; UBIDECARENONE 12 [hp_X]/mL; CONIUM MACULATUM FLOWERING TOP 9 [hp_X]/mL; ASTERIAS RUBENS 12 [hp_X]/mL; GERMANIUM 16 [hp_X]/mL; LACHESIS MUTA VENOM 12 [hp_X]/mL; BUFO BUFO CUTANEOUS GLAND 30 [hp_X]/mL; HUMAN BREAST TUMOR CELL 6 [hp_X]/mL; PHOSPHORUS 8 [hp_X]/mL	Jul 22, 2026	Aug 19, 2026
Nutritional Specialties, Inc.	THUJA OCCIDENTALIS LEAFY TWIG 12 [hp_X]/mL; UBIDECARENONE 15 [hp_X]/mL; CONIUM MACULATUM FLOWERING TOP 9 [hp_X]/mL; ASTERIAS RUBENS 15 [hp_X]/mL; GERMANIUM 16 [hp_X]/mL; LACHESIS MUTA VENOM 12 [hp_X]/mL; BUFO BUFO CUTANEOUS GLAND 30 [hp_X]/mL; HUMAN BREAST TUMOR CELL 6 [hp_X]/mL; PHOSPHORUS 8 [hp_X]/mL	Jul 22, 2026	Aug 19, 2026
Nutritional Specialties, Inc.	ASTERIAS RUBENS 12 [hp_X]/mL; BUFO BUFO CUTANEOUS GLAND 12 [hp_X]/mL; CONIUM MACULATUM FLOWERING TOP 9 [hp_X]/mL; GERMANIUM 12 [hp_X]/mL; HUMAN BREAST TUMOR CELL 16 [hp_X]/mL; LACHESIS MUTA VENOM 12 [hp_X]/mL; PHOSPHORUS 30 [hp_X]/mL; THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/mL; UBIDECARENONE 8 [hp_X]/mL	Jul 15, 2026	Jul 15, 2026
Nutritional Specialties, Inc.	ASTERIAS RUBENS 12 [hp_X]/mL; BUFO BUFO CUTANEOUS GLAND 15 [hp_X]/mL; CONIUM MACULATUM FLOWERING TOP 9 [hp_X]/mL; GERMANIUM 15 [hp_X]/mL; HUMAN BREAST TUMOR CELL 16 [hp_X]/mL; LACHESIS MUTA VENOM 12 [hp_X]/mL; PHOSPHORUS 30 [hp_X]/mL; THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/mL; UBIDECARENONE 8 [hp_X]/mL	Jul 15, 2026	Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Degex Liquescence — NDC 83027-0154-01," retrieved September 3, 2026, https://drugdashboards.com/drug/83027015401.

Free to cite with attribution — see how the data is put together.